Skip to content

RingLoc Constrained Liner

by Biomet, Inc.

510(k) K950202

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK950202 Date15 May 1995ClearedStatusActive

Official records

From the FDA record

Received by the FDA
18 Jan 1995
FDA decision
15 May 1995 (Substantially Equivalent)
FDA review time
117 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K950202 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
KWZ
Device class
Class II
Regulation
21 CFR Part 888.3310
Advisory committee
Orthopedic
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The RingLoc Constrained Liner is classified as an acetabular component for total hip arthroplasty, designed to enhance stability in high-risk patients. It features a constrained design to reduce dislocation risk, particularly in cases involving prior dislocations, bone loss, or soft tissue laxity. This device is intended for use in both primary and revision hip replacements, providing improved congruity between the liner and metal shell. Its mechanism is engineered to maximize fixation strength and resistance to lever-out or push-out forces.

The RingLoc Constrained Liner is supplied as a reusable orthopedic implant and is intended for surgical use in controlled clinical settings. It is not described as sterile in the provided data but is regulated under the FDA’s 510(k) clearance pathway, classified under the product code KWZ and reviewed by the Orthopedic (OR) Advisory Committee. The device was cleared in 1995 under the Traditional 510(k) process, with no explicit mention of MRI safety or specific sizing details in the available specifications. Authorizations are limited to the stated FDA clearance, and no additional regulatory markings or certifications are referenced.

Similar devices

Other devices filed under FDA product code KWZ (Prosthesis, Hip, Constrained, Cemented Or Uncemented, Metal/Polymer).

Other devices from Biomet, Inc.

See all devices from Biomet, Inc. →